Imipramine

Back to search

Molecule Structure

Scientific Name

Imipramine

Description of the Drug

Imipramine is a tricyclic antidepressant indicated for the treatment of depression and to reduce childhood enuresis.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00458

Brand Name(s)

Not Available

Company Owner(s)

Sun Pharmaceutical Industries Inc, Watson Laboratories Inc, Abbott Laboratories Pharmaceutical Products Div, Alra Laboratories Inc, Chartwell Life Molecules Llc, Novartis Pharmaceuticals Corp, Rising Pharma Holdings Inc, Teva Pharmaceuticals Usa Inc, Lederle Laboratories Div American Cyanamid Co, Specgx Llc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Norepinephrine transporter SINGLE PROTEIN INHIBITOR CHEMBL222
Serotonin transporter SINGLE PROTEIN INHIBITOR CHEMBL228

Unichem Links

Atlas imipramine
SureChEMBL SCHEMBL34282
PharmGKB PA449969
Human Metabolome Database HMDB0001848
DrugBank DB00458
PubChem: Thomson Pharma 15222228
PubChem 3696
Mcule MCULE-9471074673
NMRShiftDB 20147315
LINCS LSM-2852
Nikkaji J8.587A
PDBe IXX
BindingDB 50010859
EPA CompTox Dashboard DTXSID1043881
DrugCentral 1427
Brenda 1618 75631
ChemicalBook CB1727489
Guide to Pharmacology 357
rxnorm IMIPRAMINE HYDROCHLORIDE IMIPRAMINE PAMOATE TOFRANIL IMIPRAMINE
KEGG Ligand C07049
ChEBI 47499
ZINC ZINC000000020245